New Drugs for NASH and HIV Infection: Great Expectations for a Great Need-Reference-Cited by-同舟云学术

New Drugs for NASH and HIV Infection: Great Expectations for a Great Need

Published:2020-04-29 Issue:5 Volume:71 Page:1831-1844
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Guaraldi Giovanni¹^ORCID,Maurice James B.²,Marzolini Catia³,Monteith Kenneth⁴,Milic Jovana¹⁵,Tsochatzis Emmanuel⁶^ORCID,Bhagani Sanjay⁷,Morse Caryn G.⁸,Price Jennifer C.⁹,Ingiliz Patrick¹⁰¹¹,Lemoine Maud¹²,Sebastiani Giada¹³¹⁴^ORCID,

Affiliation:

1. Department of Surgical Medical, Dental and Morphological Sciences University of Modena and Reggio Emilia Modena Italy

2. Hepatology Unit Department of Surgery and Cancer Imperial College London London United Kingdom

3. Division of Infectious Diseases & Hospital Epidemiology University Hospital Basel Basel Switzerland

4. Coalition des Organismes Communautaires Québécois de Lutte Contre le Sida Montréal QC Canada

5. Clinical and Experimental Medicine PhD Program University of Modena and Reggio Emilia Modena Italy

6. UCL Institute for Liver and Digestive Health Royal Free Hospital University College London London United Kingdom

7. Royal Free London NHS Foundation Trust London United Kingdom

8. Wake Forest School of Medicine Medical Center Boulevard Winston‐Salem NC

9. Department of Medicine University of California San Francisco CA

10. Center for Infectiology Berlin Germany

11. Department of Gastroenterology and Hepatology Charité University Medical Center Berlin Germany

12. Department of Surgery and Cancer Liver Unit St Mary’s Hospital Imperial College London London United Kingdom

13. Division of Gastroenterology and Hepatology McGill University Health Centre Royal Victoria Hospital ‐ Site Glen Montréal QC Canada

14. Division of Infectious Diseases McGill University Health Center Royal Victoria Hospital–Site Glen Montréal QC Canada

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31177

Reference80 articles.

1. The First International Workshop Network Steatohepatitis in HIV Emerging Research (SHIVER).https://www.fourwav.es/view/1167/info/. Accessed December 30 2019.

2. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

3. Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States

4. NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances

5. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Steatotic liver disease and HIV: an agenda for 2030;The Lancet HIV;2024-08

2. Metabolic Dysfunction-Associated Steatotic Liver Disease in People Living with HIV—Limitations on Antiretroviral Therapy Selection;Life;2024-06-10

3. The effect of weight gain and metabolic dysfunction-associated steatotic liver disease on liver fibrosis progression and regression in people with HIV;AIDS;2024-04-18

4. Switch to a raltegravir‐based antiretroviral regimen in people with HIV and non‐alcoholic fatty liver disease: A randomized controlled trial;HIV Medicine;2023-08-28

5. Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort;BMJ Open;2023-08